Market Tracker

04/28 2:17pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

22.01
Delayed Data
As of 2:01pm ET
 +0.02 / +0.09%
Today’s Change
12.50
Today|||52-Week Range
26.89
+30.55%
Year-to-Date

Today’s Trading

Previous close21.99
Today’s open21.92
Day’s range20.75 - 22.52
Volume284,169
Average volume (3 months)439,335
Market cap$636.1M
Dividend yield--
Data as of 2:01pm ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-3.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book6.10

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.11+0.84%
ENTAEnanta Pharmaceutica...-0.21-0.59%
CORTCorcept Therapeutics...+0.07+1.13%
AMPHAmphastar Pharmaceut...-0.11-0.73%
Data as of 2:15pm ET, 04/28/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts